MKN-45 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Gastric cancer cell lines |
| Organism |
Human |
| Donor History |
Gastric adenocarcinoma |
| Growth Properties |
Adherent/suspension |
| Growth Conditions |
Culture medium: RPMI 1640 ,w: 2.0 mM stable Glutamine ,w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 20% heat-inactivated FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The MKN-45 cell line is a human gastric cancer cell line, derived from the poorly differentiated adenocarcinoma of the stomach. These cells exhibit characteristics typical of gastric cancer, including rapid growth and a high degree of genetic instability. MKN-45 cells are commonly used in cancer research to study tumor biology, drug resistance mechanisms, and the molecular pathways involved in gastric cancer progression. Their ability to form tumors when xenografted into immunocompromised mice makes them a valuable model for in vivo studies.
MKN-45 cells are epithelial in nature and grow as adherent cells in culture. They express various biomarkers relevant to gastric cancer, such as carcinoembryonic antigen (CEA) and E-cadherin, making them useful for diagnostic and therapeutic research. Additionally, MKN-45 cells are often utilized in the evaluation of chemotherapy drugs and targeted therapies due to their responsiveness to treatment and their ability to mimic the clinical behavior of human gastric tumors. Researchers also use this cell line to explore the effects of genetic modifications and to develop new therapeutic strategies aimed at improving patient outcomes in gastric cancer.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

